Tobramycin

NDC 76204-029 · Ritedose Pharmaceuticals, LLC

Generic nameTobramycin

Dosage formSOLUTION

RouteRESPIRATORY (INHALATION)

Active ingredient(s)TOBRAMYCIN

Strength300 mg/5mL

Pharmacologic classAminoglycoside Antibacterial [EPC], Aminoglycosides [CS]

Marketing categoryANDA

Packages

76204-029-56 — 14 POUCH in 1 CARTON (76204-029-56) / 4 AMPULE in 1 POUCH / 5 mL in 1 AMPULE

Billed under HCPCS

J7682 — Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams Medicare Part B payment limit (ASP + 6%): $12.30

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

70756-604 — Tobramycin, 70756-617 — Tobramycin, 71205-101 — Tobramycin, 71335-2840 — tobramycin and dexamethasone, 71335-2854 — tobramycin and dexamethasone, 71335-2891 — tobramycin and dexamethasone, 71776-035 — tobramycin / dexamethasone, 72162-1128 — tobramycin and dexamethasone, 72603-430 — Tobramycin, 72603-630 — Tobramycin, 76420-092 — Tobramycin, 76420-791 — Tobramycin, 80425-0260 — Tobramycin and dexamethasone, 80425-0341 — Tobramycin, 80425-0366 — Tobramycin and Dexamethasone, 82260-358 — loteprednol etabonate and tobramycin, 82667-011 — tobramycin / dexamethasone, 85766-025 — Tobramycin, 85766-188 — Tobramycin and Dexamethasone, 85766-189 — Tobramycin, +58 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.